Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C14H23BrNO3.I |
| Molecular Weight | 460.146 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[I-].CC[N+](C)(CC)CCC(C)OC(=O)C1=CC=C(Br)O1
InChI
InChIKey=KROWHJNUJMVHNU-UHFFFAOYSA-M
InChI=1S/C14H23BrNO3.HI/c1-5-16(4,6-2)10-9-11(3)18-14(17)12-7-8-13(15)19-12;/h7-8,11H,5-6,9-10H2,1-4H3;1H/q+1;/p-1
| Molecular Formula | HI |
| Molecular Weight | 127.91241 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C14H23BrNO3 |
| Molecular Weight | 333.241 |
| Charge | 1 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Fubromegan, a ganglionic blocking agent as an iodide salt, FUBROGONIUM IODIDE was used in Russia in patients with peptic ulcer and in the symptomatic therapy of patients with pneumoconioses. The antispasmodic effect of fubromegan was due to the effect on m- and n-cholinergic structures of smooth muscles and ganglia.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [COMPARATIVE EVALUATION OF THE EFFECT OF CHOLINOLYTIC DRUGS (HEXONIUM, FUBROMEGAN AND QUATALERON) ON THE DEVELOPMENT OF EXPERIMENTAL ULCER]. | 1963-11-01 |
|
| [Quateleron and Fubromegan in the treatment of peptic ulcer]. | 1961-12 |
|
| [Effect of fubromegan on the motor-evacuation activity of the stomach (roentgenological studies)]. | 1961-11 |
|
| [Use of a new domestic preparation fubromegan in the treatment of peptic ulcer]. | 1961-11 |
|
| [Roentgenological studies on the effect of fubromegan in dyskinesias of the biliary tract]. | 1961 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.webapteka.ru/drugbase/name7133.html
the initial dosage: 30 mg with increasing up to 60-100 мmg. 2-3 times/day during 2-3 weeks
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:20:00 GMT 2025
by
admin
on
Mon Mar 31 18:20:00 GMT 2025
|
| Record UNII |
4791MN0PVE
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29696
Created by
admin on Mon Mar 31 18:20:00 GMT 2025 , Edited by admin on Mon Mar 31 18:20:00 GMT 2025
|
||
|
NCI_THESAURUS |
C66886
Created by
admin on Mon Mar 31 18:20:00 GMT 2025 , Edited by admin on Mon Mar 31 18:20:00 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB07824MIG
Created by
admin on Mon Mar 31 18:20:00 GMT 2025 , Edited by admin on Mon Mar 31 18:20:00 GMT 2025
|
PRIMARY | |||
|
2433
Created by
admin on Mon Mar 31 18:20:00 GMT 2025 , Edited by admin on Mon Mar 31 18:20:00 GMT 2025
|
PRIMARY | |||
|
C007788
Created by
admin on Mon Mar 31 18:20:00 GMT 2025 , Edited by admin on Mon Mar 31 18:20:00 GMT 2025
|
PRIMARY | |||
|
71529
Created by
admin on Mon Mar 31 18:20:00 GMT 2025 , Edited by admin on Mon Mar 31 18:20:00 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110930
Created by
admin on Mon Mar 31 18:20:00 GMT 2025 , Edited by admin on Mon Mar 31 18:20:00 GMT 2025
|
PRIMARY | |||
|
3690-58-2
Created by
admin on Mon Mar 31 18:20:00 GMT 2025 , Edited by admin on Mon Mar 31 18:20:00 GMT 2025
|
PRIMARY | |||
|
DTXSID90958102
Created by
admin on Mon Mar 31 18:20:00 GMT 2025 , Edited by admin on Mon Mar 31 18:20:00 GMT 2025
|
PRIMARY | |||
|
4791MN0PVE
Created by
admin on Mon Mar 31 18:20:00 GMT 2025 , Edited by admin on Mon Mar 31 18:20:00 GMT 2025
|
PRIMARY | |||
|
100000080671
Created by
admin on Mon Mar 31 18:20:00 GMT 2025 , Edited by admin on Mon Mar 31 18:20:00 GMT 2025
|
PRIMARY | |||
|
C65776
Created by
admin on Mon Mar 31 18:20:00 GMT 2025 , Edited by admin on Mon Mar 31 18:20:00 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
PARENT -> SALT/SOLVATE | |||
|
|
ENANTIOMER -> RACEMATE |